What is Sinopharm Group Co Operating Cash Flow per Share?
Sinopharm Group Co's operating cash flow per share for the
six
months ended in Dec. 2024 was $2.31.
Sinopharm Group Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.50.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sinopharm Group Co was -34.40% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -3.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Sinopharm Group Co's Operating Cash Flow per Share or its related term are showing as below:
SHTDF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -37.9 Med: 22.6 Max: 72
Current: 2.5
During the past 13 years, Sinopharm Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.00% per year. The lowest was -37.90% per year. And the median was 22.60% per year.
SHTDF's 3-Year OCF Growth Rate is ranked worse than 52.56% of 78
companies
in the Medical Distribution industry
Industry Median: 3.25
vs SHTDF: 2.50
Sinopharm Group Co Operating Cash Flow per Share Historical Data
The historical data trend for Sinopharm Group Co's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sinopharm Group Co Operating Cash Flow per Share Chart
Competitive Comparison of Sinopharm Group Co's Operating Cash Flow per Share
For the Medical Distribution subindustry, Sinopharm Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co's Price-to-Operating-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDF has been successfully added to your 